Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Simonetti

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Scientific Reports|January 30, 2020
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerFrancesco Pantano, Elisabetta Rossi, Michele Iuliani, et al.
International Journal of Molecular Sciences|March 10, 2022
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone MicroenvironmentMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
European Journal of Immunology|February 14, 2019
Dendritic cells modulate c-kit expression on the edge between activation and deathSonia Simonetti, Amairelys B Barroeta Seijas, Ambra Natalini, et al.
Cell Biochemistry and Function|September 7, 2022
Mouse dendritic cells in the steady state: Hypoxia, autophagy, and stem cell factorAmairelys Belen Barroeta Seijas, Sonia Simonetti, Irene Filippi, et al.
Journal of Translational Medicine|January 17, 2026
Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non-small cell lung cancerSilvia Cavaliere, Marta Fogolari, Michele Iuliani, et al.
Expert Opinion on Biological Therapy|August 25, 2020
Denosumab for cancer-related bone lossEmanuela Dell'Aquila, Grazia Armento, Michele Iuliani, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2020
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2020
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Bone Oncology|November 7, 2022
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysisFrancesco Pantano, Flavia Tramontana, Michele Iuliani, et al.
Frontiers in Immunology|March 7, 2017
GM-CSF Inhibits c-Kit and SCF Expression by Bone Marrow-Derived Dendritic CellsAmairelys Belen Barroeta Seijas, Sonia Simonetti, Sara Vitale, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Scientific Reports|January 30, 2020
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerFrancesco Pantano, Elisabetta Rossi, Michele Iuliani, et al.
International Journal of Molecular Sciences|March 10, 2022
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone MicroenvironmentMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
European Journal of Immunology|February 14, 2019
Dendritic cells modulate c-kit expression on the edge between activation and deathSonia Simonetti, Amairelys B Barroeta Seijas, Ambra Natalini, et al.
Cell Biochemistry and Function|September 7, 2022
Mouse dendritic cells in the steady state: Hypoxia, autophagy, and stem cell factorAmairelys Belen Barroeta Seijas, Sonia Simonetti, Irene Filippi, et al.
Journal of Translational Medicine|January 17, 2026
Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non-small cell lung cancerSilvia Cavaliere, Marta Fogolari, Michele Iuliani, et al.
Expert Opinion on Biological Therapy|August 25, 2020
Denosumab for cancer-related bone lossEmanuela Dell'Aquila, Grazia Armento, Michele Iuliani, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2020
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2020
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Bone Oncology|November 7, 2022
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysisFrancesco Pantano, Flavia Tramontana, Michele Iuliani, et al.
Frontiers in Immunology|March 7, 2017
GM-CSF Inhibits c-Kit and SCF Expression by Bone Marrow-Derived Dendritic CellsAmairelys Belen Barroeta Seijas, Sonia Simonetti, Sara Vitale, et al.
Pageof 3